a public good project by the
Synthesis
Company
of California

© 2026

Zejing Wang | doi.page

0 works0 citations0 h-index

Zejing Wang

Aston University(GB)Xingtai University(CN)

Publications by Year

Research Areas

Blood properties and coagulation, Virus-based gene therapy research, Muscle Physiology and Disorders, Monoclonal and Polyclonal Antibodies Research, Tissue Engineering and Regenerative Medicine

Most-Cited Works

→ Increased AKT Activity Contributes to Prostate Cancer Progression by Dramatically Accelerating Prostate Tumor Growth and Diminishing p27Kip1 Expression(2000)380 cited
→ Sustained AAV-mediated Dystrophin Expression in a Canine Model of Duchenne Muscular Dystrophy with a Brief Course of Immunosuppression(2007)213 cited
→ Dystrophin-deficient cardiomyocytes derived from human urine: New biologic reagents for drug discovery(2013)135 cited
→ Fibronectin-Tissue Transglutaminase Matrix Rescues RGD-impaired Cell Adhesion through Syndecan-4 and β1 Integrin Co-signaling(2008)128 cited
→ Immunity to Adeno-Associated Virus-Mediated Gene Transfer in a Random-Bred Canine Model of Duchenne Muscular Dystrophy(2007)123 cited
→ TG2, a novel extracellular protein with multiple functions(2011)117 cited

→ Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor(2018)

92 cited

→ RGD-independent Cell Adhesion via a Tissue Transglutaminase-Fibronectin Matrix Promotes Fibronectin Fibril Deposition and Requires Syndecan-4/2 and α5β1 Integrin Co-signaling(2010)83 cited

→ Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs(2004)81 cited